Ventripoint Diagnostics Stock Target Price
VPTDF Stock | USD 0.09 0.01 6.10% |
Fundamental analysis of VentriPoint Diagnostics allows traders to better anticipate movements in VentriPoint Diagnostics' stock price by examining its financial health and performance throughout various phases of its business cycle.
VentriPoint |
Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
All Next | Launch Module |
VentriPoint Fundamentals
Return On Equity | -1.35 | |||
Return On Asset | -0.64 | |||
Operating Margin | (124.50) % | |||
Current Valuation | 28.27 M | |||
Shares Outstanding | 156.51 M | |||
Shares Owned By Insiders | 1.75 % | |||
Price To Earning | 68.00 X | |||
Price To Book | 8.27 X | |||
Price To Sales | 897.04 X | |||
Gross Profit | (6.27 K) | |||
EBITDA | (3.82 M) | |||
Net Income | (3.88 M) | |||
Cash And Equivalents | 7.29 M | |||
Cash Per Share | 0.05 X | |||
Total Debt | 125.38 K | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 6.74 X | |||
Book Value Per Share | 0.03 X | |||
Cash Flow From Operations | (3.15 M) | |||
Earnings Per Share | (0.02) X | |||
Number Of Employees | 17 | |||
Beta | 0.28 | |||
Market Capitalization | 32.09 M | |||
Total Asset | 9.54 M | |||
Retained Earnings | (20.43 M) | |||
Working Capital | (1.99 M) | |||
Current Asset | 1.07 M | |||
Current Liabilities | 3.05 M | |||
Net Asset | 9.54 M |
About VentriPoint Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VentriPoint Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VentriPoint Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VentriPoint Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
USOI | Credit Suisse X Links | |
ULTY | Tidal Trust II | |
CONY | YieldMax N Option | |
BCAT | BlackRock Capital Allocation | |
PDI | Pimco Dynamic Income |
Other Information on Investing in VentriPoint Pink Sheet
VentriPoint Diagnostics financial ratios help investors to determine whether VentriPoint Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VentriPoint with respect to the benefits of owning VentriPoint Diagnostics security.